Trial Profile
Prophylactic Efficacy of Relenza Against Influenza A and B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary) ; Amantadine; Oseltamivir; Rimantadine
- Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 22 Jul 2010 New trial record